ArticleBritish journal of cancer2014

Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma.

A Patnaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.